Literature DB >> 10817503

High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients.

H Yamamoto1, T Nakayama, H Murakami, T Hosaka, T Nakamata, T Tsuboyama, M Oka, T Nakamura, J Toguchida.   

Abstract

Recent studies have revealed the evidence for the significance of SV40 genome in human malignancies. In this paper, the presence of SV40-like sequences was investigated in 54 Japanese osteosarcomas in which mutations of the retinoblastoma (Rb), p53, MDM2, and CDK4 genes had been already analysed. Using polymerase chain reaction and Southern hybridization, SV40-like sequences were detected in 25 cases (46.3%). In most cases, only a part of SV40 genome was detected, and the regulatory region containing enhancer sequences was most frequently found (21/54, 38.9%). There was no apparent relationship between the presence of SV40-like sequences and tumour suppressor genes mutations in each tumour. The SV40-like sequences were also detected in peripheral blood cells of substantial proportion of the patients (43.3%), whereas the incidence was much lower (4.7%) in normal healthy controls. This difference is statistically highly significant (P < 0.0001), suggesting that the presence of SV40-like sequences, even if only a part, may play some roles to predispose individuals to osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817503      PMCID: PMC2374501          DOI: 10.1054/bjoc.2000.1213

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

Review 1.  Structure and function of simian virus 40 large tumor antigen.

Authors:  E Fanning; R Knippers
Journal:  Annu Rev Biochem       Date:  1992       Impact factor: 23.643

2.  The vacuolating virus, S.V. 40.

Authors:  B H SWEET; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1960-11

Review 3.  Human exposure to SV40: review and comment.

Authors:  K Shah; N Nathanson
Journal:  Am J Epidemiol       Date:  1976-01       Impact factor: 4.897

4.  The genome of simian virus 40.

Authors:  V B Reddy; B Thimmappaya; R Dhar; K N Subramanian; B S Zain; J Pan; P K Ghosh; M L Celma; S M Weissman
Journal:  Science       Date:  1978-05-05       Impact factor: 47.728

5.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice.

Authors:  C Ledent; J Dumont; G Vassart; M Parmentier
Journal:  Endocrinology       Date:  1991-09       Impact factor: 4.736

6.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

7.  DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood.

Authors:  D J Bergsagel; M J Finegold; J S Butel; W J Kupsky; R L Garcea
Journal:  N Engl J Med       Date:  1992-04-09       Impact factor: 91.245

8.  Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40.

Authors:  G T Diamandopoulos
Journal:  Science       Date:  1972-04-14       Impact factor: 47.728

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.

Authors:  S H Friend; R Bernards; S Rogelj; R A Weinberg; J M Rapaport; D M Albert; T P Dryja
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

View more
  21 in total

1.  Simian virus 40 infection of humans.

Authors:  Robert L Garcea; Michael J Imperiale
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

Review 2.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

3.  Immunodetection of SV40 T/t-antigens in human osteosrcoma in a series of Tunisian patients.

Authors:  S Ziadi; H Boughamoura; M Ben Maitig; R Ben Gacem; S Mestiri; L Chaabani; M Trimeche
Journal:  Pathol Oncol Res       Date:  2012-07       Impact factor: 3.201

4.  Immunolocalization of caveolin-1 in rat and human mesothelium.

Authors:  Christopher J von Ruhland; Lee Campbell; Mark Gumbleton; Bharat Jasani; Geoffrey R Newman
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

5.  Tissue Tropism of SV40 Transformation of Human Cells: Role of the Viral Regulatory Region and of Cellular Oncogenes.

Authors:  Lei Zhang; Fang Qi; Giovanni Gaudino; Oriana Strianese; Haining Yang; Paul Morris; Harvey I Pass; Vivek R Nerurkar; Maurizio Bocchetta; Michele Carbone
Journal:  Genes Cancer       Date:  2010-10

Review 6.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Inability of simian virus 40 to establish productive infection of lymphoblastic cell lines.

Authors:  Sophie Shaikh; Christine Skoczylas; Richard Longnecker; Kathleen Rundell
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

Review 8.  Simian virus 40 and its association with human lymphomas.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

9.  Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.

Authors:  Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Giuseppe P Segoloni; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

10.  Ovarian cancer mouse models: a summary of current models and their limitations.

Authors:  Miranda Y Fong; Sham S Kakar
Journal:  J Ovarian Res       Date:  2009-09-28       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.